Quantum Computing

SandboxAQ's new AI model, 20,000x faster than simulation, is the first to model magnetism in catalysts, unlocking sustainable innovation for global industries.

A Quebec startup's strategic hires reveal a critical shift in the quantum race, where translating science into value is now as vital as the breakthroughs themselves.

German firm NVision wins a top award for POLARIS, a quantum-enhanced MRI platform that shows if cancer therapy is working weeks or months sooner.

EeroQ's breakthrough with electrons on helium opens a new front in the quantum race, promising a scalable path to millions of qubits via standard chip tech.

With fresh capital, SuperQ Quantum aims to move from niche deep tech to mainstream tool. But can its hybrid strategy and global push justify the investment?

The financial giant extends its massive Security and Resiliency Initiative north, targeting defense, energy, and supply chains to bolster regional stability.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

New pacts on defence, quantum tech, and climate resilience signal a shift in Canadian foreign policy, transforming historic ties into a modern economic engine.

Beyond the accolades, the American National Standards Institute’s latest awards reveal the unsung heroes building our technological and economic future.

SEALSQ's CEO leads a crucial quantum semiconductor talk in Munich, highlighting the race to scale quantum tech and the urgent need for post-quantum security.

A novel TYK2 inhibitor that can enter the central nervous system has begun human trials, signaling a new frontier for treating diseases like MS and lupus.

Semiconductor legend Scott McGregor takes the helm at Diraq, signaling a pivotal shift to commercialize quantum computing using the world's existing chip factories.

A pharma revolution is brewing for Generalized Anxiety Disorder. As prevalence soars, novel therapies targeting new neural pathways promise to upend the market.

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

With its acquisition of photonics pioneer Miraex, SEALSQ claims it has the final piece for a sovereign quantum network spanning from silicon to space.

As AI reshapes finance, BMO's award-winning leaders are pioneering a human-first approach, integrating digital innovation and quantum readiness to redefine the 2026 consumer experience and the 'why behind the buy'.

The government is set to announce a new wave of research awards, part of a $1.7B strategy to attract top international scientists and fuel innovation.

Guggenheim Securities taps veteran analyst Michael Ciarmoli to lead its aerospace and defense tech research amid a sector boom fueled by new tech and spending.

The photonic quantum firm gets flexible funding to scale its tech, but investors must weigh the promise of growth against the risk of stock dilution.